Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
Paul Moayyedi, John W. Eikelboom, Jackie Bosch, et al.
Gastroenterology (2019) Vol. 157, Iss. 3, pp. 682-691.e2
Open Access | Times Cited: 398

Showing 26-50 of 398 citing articles:

Gastritis, Gastric Polyps and Gastric Cancer
Helge L. Waldum, Reidar Fossmark
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6548-6548
Open Access | Times Cited: 98
Proton pump inhibitors and risk of gastric cancer: population-based cohort study
Devin Abrahami, Emily G. McDonald, Mireille E. Schnitzer, et al.
Gut (2021) Vol. 71, Iss. 1, pp. 16-24
Open Access | Times Cited: 93
2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease
Hye‐Kyung Jung, Chung Hyun Tae, Kyung Ho Song, et al.
Journal of Neurogastroenterology and Motility (2021) Vol. 27, Iss. 4, pp. 453-481
Open Access | Times Cited: 93
Problems Associated with Deprescribing of Proton Pump Inhibitors
Hólmfríður Helgadóttir, Einar S. Björnsson
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5469-5469
Open Access | Times Cited: 78
Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial
Lucas Wauters, Helena Slaets, Kim De Paepe, et al.
˜The œLancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 10, pp. 784-792
Closed Access | Times Cited: 70
Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts
Bin Xia, Man Yang, Long H. Nguyen, et al.
Gastroenterology (2021) Vol. 161, Iss. 6, pp. 1842-1852.e10
Open Access | Times Cited: 65
Umbrella review of 42 systematic reviews with meta‐analyses: the safety of proton pump inhibitors
Elizabeth M. Salvo‐Halloran, Nicole Ferko, Sarah B. Cash, et al.
Alimentary Pharmacology & Therapeutics (2021) Vol. 54, Iss. 2, pp. 129-143
Closed Access | Times Cited: 56
Clinical guidance for the use of dupilumab in eosinophilic esophagitis
Seema S. Aceves, Evan S. Dellon, Matthew Greenhawt, et al.
Annals of Allergy Asthma & Immunology (2022) Vol. 130, Iss. 3, pp. 371-378
Closed Access | Times Cited: 53
Gastroesophageal Reflux Disease
Ronnie Fass
New England Journal of Medicine (2022) Vol. 387, Iss. 13, pp. 1207-1216
Closed Access | Times Cited: 45
Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: History, Mechanisms, Efficacy, and Future Directions
James P. Franciosi, Edward B. Mougey, Evan S. Dellon, et al.
Journal of Asthma and Allergy (2022) Vol. Volume 15, pp. 281-302
Open Access | Times Cited: 43
Multiple secondary outcome analyses: precise interpretation is important
Richard A. Parker, Christopher J. Weir
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 39
S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013

Zeitschrift für Gastroenterologie (2023) Vol. 61, Iss. 07, pp. 862-933
Open Access | Times Cited: 27
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring
Nicola de Bortoli, Pierfrancesco Visaggi, Roberto Penagini, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 7, pp. 1173-1184
Closed Access | Times Cited: 14
AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review
Amit Patel, Loren Laine, Paul Moayyedi, et al.
Gastroenterology (2024)
Closed Access | Times Cited: 8
The Phylogeny and Biological Function of Gastric Juice—Microbiological Consequences of Removing Gastric Acid
Tom C. Martinsen, Reidar Fossmark, Helge L. Waldum
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6031-6031
Open Access | Times Cited: 70
Proton Pump Inhibitors Reduce Duodenal Eosinophilia, Mast Cells, and Permeability in Patients With Functional Dyspepsia
Lucas Wauters, Matthias Ceulemans, Dennis Frings, et al.
Gastroenterology (2020) Vol. 160, Iss. 5, pp. 1521-1531.e9
Open Access | Times Cited: 67
Association Between Proton Pump Inhibitor Use and Risk of Fracture in Children
Yunhan Wang, Viktor Wintzell, Jonas F. Ludvigsson, et al.
JAMA Pediatrics (2020) Vol. 174, Iss. 6, pp. 543-543
Open Access | Times Cited: 57
Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies
Jinqiu Yuan, Qiangsheng He, Long H. Nguyen, et al.
Gut (2020) Vol. 70, Iss. 6, pp. 1070-1077
Closed Access | Times Cited: 57
Proton pump inhibitors, adverse events and increased risk of mortality
Aitor Lanas-Gimeno, Gonzalo Hijos, Fernando Laņas
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 11, pp. 1043-1053
Closed Access | Times Cited: 55
GERD: A practical approach
Andrew Young, Mythri Anil Kumar, Prashanthi N. Thota
Cleveland Clinic Journal of Medicine (2020) Vol. 87, Iss. 4, pp. 223-230
Open Access | Times Cited: 54
COVID-19-associated diarrhea
Klára Megyeri, Áron Dernovics, Zaid Isam Issa Al-Luhaibi, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 23, pp. 3208-3222
Open Access | Times Cited: 51
Salivary microbiome with gastroesophageal reflux disease and treatment
Nadia Kawar, Seon Gyeong Park, Joel Schwartz, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 49
Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes
Stacy Weitsman, Shreya Celly, Gabriela Leite, et al.
Digestive Diseases and Sciences (2021) Vol. 67, Iss. 1, pp. 224-232
Closed Access | Times Cited: 43
Controversies in the Prevention and Treatment of Clostridioides difficile Infection in Adults: A Narrative Review
Taryn B. Bainum, Kelly R. Reveles, Ronald G. Hall, et al.
Microorganisms (2023) Vol. 11, Iss. 2, pp. 387-387
Open Access | Times Cited: 21
Proton pump inhibitors: Understanding the associated risks and benefits of long-term use
Kristina M. Thurber, Ashley O Otto, Shawna L Stricker
American Journal of Health-System Pharmacy (2023) Vol. 80, Iss. 8, pp. 487-494
Closed Access | Times Cited: 20

Scroll to top